HeimMEHCQ • OTCMKTS
add
Chrome Holding Co
Við síðustu lokun
3,60 $
Dagbil
3,45 $ - 3,57 $
Árabil
0,47 $ - 6,21 $
Markaðsvirði
96,40 m. USD
Meðalmagn
125,12 þ.
V/H-hlutf.
-
A/V-hlutfall
-
Aðalkauphöll
OTCMKTS
Í fréttum
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (USD) | jún. 2025info | Breyting á/á |
|---|---|---|
Tekjur | 25,42 m. | -37,10% |
Rekstrarkostnaður | 44,24 m. | -43,21% |
Nettótekjur | -23,83 m. | 65,67% |
Hagnaðarhlutfall | -93,74 | 45,41% |
Hagnaður á hvern hlut | — | — |
EBITDA | -28,49 m. | 46,78% |
Virkt skatthlutfall | — | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (USD) | jún. 2025info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 39,83 m. | -76,57% |
Heildareignir | 144,33 m. | -60,79% |
Heildarskuldir | 187,19 m. | -16,64% |
Eigið fé alls | -42,86 m. | — |
Útistandandi hlutabréf | 27,54 m. | — |
Eiginfjárgengi | -2,31 | — |
Arðsemi eigna | -50,47% | — |
Ávöxtun eigin fjár | 438,85% | — |
Peningaflæði
Breyting á handbæru fé
| (USD) | jún. 2025info | Breyting á/á |
|---|---|---|
Nettótekjur | -23,83 m. | 65,67% |
Handbært fé frá rekstri | -28,99 m. | 33,00% |
Reiðufé frá fjárfestingum | -1,03 m. | 10,64% |
Reiðufé frá fjármögnun | 24,28 m. | 269.711,11% |
Breyting á handbæru fé | -5,74 m. | 87,07% |
Frjálst peningaflæði | 22,86 m. | 281,90% |
Um
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a diploid human cell.
Founded in 2006, 23andMe soon became the first company to begin offering autosomal DNA testing for ancestry, which all other major companies now use. Its saliva-based direct-to-consumer genetic testing business was named "Invention of the Year" by Time in 2008.
The company had a previously confrontational relationship with the United States Food and Drug Administration due to its genetic health tests; as of October 2015, DNA tests ordered in the US include a revised health component, per FDA approval. 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014, and in the UK since December 2014. Wikipedia
Stofnsett
apr. 2006
Höfuðstöðvar
Vefsvæði
Starfsfólk
261